Is it warranted to be pessimistic about the current state of digital health? [Video]

This week on MedHeads, we took a look back at the 2016 JP Morgan Healthcare Conference. Our reporters Meghana Keshavan and Stephanie Baum were joined by guests Kenneth Clark, a partner at Wilson Sonsini Goodrich & Rosati, and venture capitalist Lisa Suennen. Chris Seper hosted the discussion.

One common theme was addressing the fact that the biotech public markets have struggled as of late and what that means for the industry currently – whether or not it makes sense to be pessimistic or cautiously optimistic.

Keshavan, Baum and Suennen all agreed that pessimism was palpable at the conference.

Suennen said, “There was a lot of optimism about the convergence of biotech, life sciences and health IT, but also there was a sense of foreboding that the party is over in some of these areas.”

“It’s definitely going to be a quiet year for IPOs in digital health,” Baum said. “I think people are going to be buckling down …